←
FOCIS-Center-of-Excellence(FCE)-PAn'THER331 posts
FOCIS-Center-of-Excellence(FCE)-PAn'THER avatar

FOCIS-Center-of-Excellence(FCE)-PAn'THER

@FCEPAnTHER

Research, education & medical care in #autoimmunity and #cell therapy at @DrOlivierBoyer_lab @Inserm @univrouen @CHURouen : #myositis, #pemphigus, #CAR T cells

◷ Joined March 2024▧ 47 Photos and videos
nature avatar
⟳ FOCIS-Center-of-Excellence(FCE)-PAn'THER retweeted
nature@Nature·Oct 5

Karl Deisseroth, Peter Hegemann and Georg Nagel win the 2026 Nobel Prize in Physiology or Medicine for their work on optogenetics, which has revolutionized neuroscience go.nature.com/4zk3Rfz

FOCIS-Center-of-Excellence(FCE)-PAn'THER avatar
FOCIS-Center-of-Excellence(FCE)-PAn'THER@FCEPAnTHER·Aug 21

FOCIS provides highest level education in immunology in many parts of the world. Congratulations to the FOCIS Goes North team for incredible course in Iceland. Where else? FOCIS Goes South 13-15OCT2026 in Montevideo. See you there. focisnet.org/education/foci… @Focis_FCE

Today is the final day of FOCIS Goes North: Iceland Cancer Immunology Conference🧬 It's been an inspiring few days of fascinating science, meaningful discussions, and great connections with colleagues from Iceland & around the world. #FOCISGoesNorth #CancerImmunology

Post attachment
FOCIS-Center-of-Excellence(FCE)-PAn'THER avatar
FOCIS-Center-of-Excellence(FCE)-PAn'THER@FCEPAnTHER·Aug 12

Splendid work about the role of TIF1γ in Tregs, a multifaceted molecule since autoantibodies targeting TIF1γ are associated to a risk of cancer in #dermatomyositis @TheMyositisAssc @Telethon_France @iuis_online @FOCISimmunology

TIF1γ is a critical regulator of Treg cell stability that restrains β-catenin–TCF7 signaling, thereby preserving Foxp3 expression and preventing inflammatory reprogramming @NatImmunol nature.com/articles/s41590-0… @LabLiconaP🇲🇽@IFC_UNAM

Post attachment
Monica Guzman avatar
⟳ FOCIS-Center-of-Excellence(FCE)-PAn'THER retweeted
Monica Guzman@DrMonicaGuzman·Aug 4

Proud to share our new piece in Blood Global Hematology, written with wonderful colleagues: @RobertaDemiche3 @castro_mollo @XimeJordan "Hispanic/Latino" was built for policy, not biology. In leukemia, treating it as one group hides real diversity in ancestry, access & disease. Rethinking Hispanic/Latino as an ethnic category in leukemia research ashpublications.org/bloodglo…

Iago Pinal-Fernandez avatar
⟳ FOCIS-Center-of-Excellence(FCE)-PAn'THER retweeted
Iago Pinal-Fernandez@DrIagoPinal·Jul 24

Excited to share our latest @ARD_BMJ study! We reveal the mechanism by which autoantibodies enter cells, disrupt their target autoantigens, and drive tissue injury and inflammation in myositis and other autoimmune diseases. 🧬 doi.org/10.1016/j.ard.2026.0…

Post attachmentPost attachmentPost attachmentPost attachment
FOCIS-Center-of-Excellence(FCE)-PAn'THER avatar
FOCIS-Center-of-Excellence(FCE)-PAn'THER@FCEPAnTHER·Jul 27

Autoantibodies enter muscle cells & block target function. Plasma cells may transfer Ig mRNA to muscle cells and cause disease. A new mechanism in #autoimmunity elucidated by @DrIagoPinal et al. @NIH @HopkinsMedicine @FOCISimmunology @iuis_online @Immunopaedia @TheMyositisAssc

#autoantibodies (aAb) functionally block intracellular autoantigens in #myositis. Do aAb enter cells? They do. Check evidence from @DrIagoPinal and colleagues @eular_ARD. Brilliant! researchgate.net/publication…

Monica Guzman avatar
⟳ FOCIS-Center-of-Excellence(FCE)-PAn'THER retweeted
Monica Guzman@DrMonicaGuzman·Jun 9

If you are at the #FOCIS2026 meeting and have questions about @FOCISimmunology, look for FOCIS Leaders wearing the "ASK ME ABOUT" pin. Need a hand networking... grab a pin with the languages you speak, great way to start a conversation and share your #immunology work. Want to share good vibes with people? Stay on the lookout for the motivational stickers! Don't forget to share the exciting work you see at the meeting!

Post attachmentPost attachmentPost attachment
NEJM avatar
⟳ FOCIS-Center-of-Excellence(FCE)-PAn'THER retweeted
NEJM@NEJM·May 31

Presented at #ASCO26: Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM @ASCO

Post attachment
Elena Hsieh avatar
⟳ FOCIS-Center-of-Excellence(FCE)-PAn'THER retweeted
Elena Hsieh@HsiehElena·May 4

Honored to be an elected member of the American Society for Clinical Investigation! @the_asci physician scientists are not a dying breed- we’re alive and kicking- and working on growing more! We will summit together! #thefutureisbright 💪

Post attachmentPost attachmentPost attachment
FOCIS avatar
⟳ FOCIS-Center-of-Excellence(FCE)-PAn'THER retweeted
FOCIS@FOCISimmunology·Apr 6

🚨We’re excited to spotlight a new publication from the FOCIS community—and that their research image is featured on the cover! 📝 Beta cell–targeted PD-1 agonist inhibits cell-mediated autoimmunity in pancreas tissue slices zurl.co/AbMBQ

Post attachment
Journal of Human Immunity avatar
⟳ FOCIS-Center-of-Excellence(FCE)-PAn'THER retweeted
Journal of Human Immunity@jhumimmunity·Mar 13

Gervais, Trespidi, Ferrari, Rovida, Cobat, Zhang, Casanova, Borghesi et al. show that, in 13 European, Middle-Eastern, and American cohorts, pre-existing autoantibodies neutralizing type I IFNs are causal for WNV encephalitis in about 40% of patients. hubs.la/Q046JZ5J0

Post attachment
FOCIS avatar
⟳ FOCIS-Center-of-Excellence(FCE)-PAn'THER retweeted
FOCIS@FOCISimmunology·Mar 9

Day 1 of the FOCIS 2026 Advanced Course is underway! Great turnout as we kick off this year’s course in a new location — Aurora, CO. Looking forward to a great week of learning and collaboration. 🧬

Post attachment